CRLComplete Response Letter
Complete Response Letter Kyowa Pharmaceutical, Inc. (Feb 25, 2008)
FDA's complete response letter contains source-text evidence related to Nonclinical evidence, Clinical efficacy and substantial evidence, Safety and adverse events. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
Issued
US FDA• NOURIANZ
